摘要
目的:探讨人参二醇组皂苷(PDS)与紫杉醇(PTX)联合应用对DUl45前列腺癌细胞增殖及凋亡的影响。方法:MTT法检测PTX单独组、PTX+地塞米松(Dex)组和PTX+PDS组SKOV3卵巢癌细胞存活的情况;流式细胞仪检测各组细胞凋亡情况;免疫印迹方法检测各组细胞活化形式caspase-3蛋白和AKT磷酸化的表达情况。结果:紫杉醇单独作用能显著的以浓度依赖性的方式降低细胞的存活,联合应用Dex后存活的SKOV3细胞数明显增加,PDS可以增加PTX对SKOV3细胞的增殖抑制作用。流式细胞仪检测细胞凋亡结果发现,PTX处理SKOV3细胞,凋亡细胞数约占总细胞数的22.38%,PTX联合Dex组其凋亡细胞数下降到总细胞数的14.52%(P<0.05),PTX联合PDS组其凋亡细胞数增加至39.54%。在SKOV3细胞中,PTX能显著诱导活化的caspase-3的表达,而Dex能够明显抑制PTX对活化的caspase-3表达的诱导作用。PDS可以促进活化的caspase-3的表达。与PTX组比较,PTX+Dex组AKT的磷酸化水平升高,而PDS可以使SKOV3细胞中的AKT的磷酸化显著降低。结论:PDS通过增强化疗药物PTX对SKOV3细胞的凋亡作用来增强对肿瘤细胞的杀伤作用。
Objective: To explore the effect of Panaxadiol saponins( PDS) combined with paclitaxel on proliferation and apoptosis of ovarian cancer SKOV3 cells. Methods: MTT assay was used to detect the survival rates of human ovarian cancer SKOV3 cells in paclitaxel group,paclitaxel + dexamethasone group and paclitaxel + PDS group; flow cytometry was used to detect apoptosis of human ovarian cancer SKOV3 cells in the three groups; Western blot was used to detect caspase-3 protein expression and p-AKT expression in the three groups. Results: Paclitaxel could significantly reduce survival rate of human ovarian cancer SKOV3 cells in a dose-dependent manner. The survival rate of human ovarian cancer SKOV3 cells in paclitaxel + dexamethasone group increased significantly,PDS could enhance the inhibiting effect of paclitaxel on proliferation of paclitaxel. The apoptotic rates of human ovarian cancer SKOV3 cells in paclitaxel group and paclitaxel + dexamethasone group were 22. 38% and 14. 52%,respectively,there was statistically significant difference between the two groups( P 0. 05); in paclitaxel + PDS group,the apoptotic rate increased to 39. 54%. Paclitaxel could significantly induce expression of activated caspase-3 in human ovarian cancer SKOV3 cells,but dexamethasone could significantly inhibit the induction effect of paclitaxel on expression of activated caspase-3 in human ovarian cancer SKOV3 cells. PDS could promote the expression of activated caspase-3. Compared with paclitaxel group,p-AKT expression level in paclitaxel + dexamethasone group increased,but PDS could significantly reduce p-AKT expression level in human ovarian cancer SKOV3 cells. Conclusion: PDS can enhance cell-killing effect by strengthening apoptotic effect of paclitaxel on ovarian cancer SKOV3 cells.
出处
《中国妇幼保健》
CAS
北大核心
2014年第35期5899-5901,共3页
Maternal and Child Health Care of China
基金
吉林省科技厅重点项目〔20110953〕
吉林省参茸办人参科研成果推广应用和转化项目〔吉参茸办2010-13号
2011-17号〕